REPORT ID 2846

China Oncolytic Virus Market Research Report 2017

Publish Date
11-Dec-17
Pages
112
Format
Electronic (PDF)

The global Oncolytic Virus market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Oncolytic Virus development status and future trend in China, focuses on top players in China, also splits Oncolytic Virus by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Merck
    Otsuka Pharmaceutical Co
    Pfizer
    Roche
    Cold Genesys
    Genelux
    Latima
    Neotropix
    Shanghai Sunway Biotech
    SillaJen
    Takara Bio
    Theravir

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    HSV-based Oncolytic Viruses
    Adenoviruses-based Oncolytic Viruses
    Vaccinia Virus-based Oncolytic Viruses
    Vesicular Stomatitis Virus-based Oncolytic Viruses
    Newcastle Disease Virus-based Oncolytic Viruses

On the basis of the end users/application, this report covers
    Pharmaceutical
    Health Care
    Commerical

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Oncolytic Virus Market Research Report 2017
1 Oncolytic Virus Overview
    1.1 Product Overview and Scope of Oncolytic Virus
    1.2 Classification of Oncolytic Virus by Product Category
        1.2.1 China Oncolytic Virus Sales (K Units) Comparison by Type (2012-2022)
        1.2.2 China Oncolytic Virus Sales (K Units) Market Share by Type in 2016
        1.2.3 HSV-based Oncolytic Viruses
        1.2.4 Adenoviruses-based Oncolytic Viruses
        1.2.5 Vaccinia Virus-based Oncolytic Viruses
        1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
        1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
    1.3 China Oncolytic Virus Market by Application/End Users
        1.3.1 China Oncolytic Virus Sales (K Units) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Pharmaceutical
        1.3.3 Health Care
        1.3.4 Commerical
    1.4 China Oncolytic Virus Market by Region
        1.4.1 China Oncolytic Virus Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Oncolytic Virus Status and Prospect (2012-2022)
        1.4.3 East China Oncolytic Virus Status and Prospect (2012-2022)
        1.4.4 Southwest China Oncolytic Virus Status and Prospect (2012-2022)
        1.4.5 Northeast China Oncolytic Virus Status and Prospect (2012-2022)
        1.4.6 North China Oncolytic Virus Status and Prospect (2012-2022)
        1.4.7 Central China Oncolytic Virus Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Oncolytic Virus (2012-2022)
        1.5.1 China Oncolytic Virus Sales (K Units) and Growth Rate (%)(2012-2022)
        1.5.2 China Oncolytic Virus Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Oncolytic Virus Market Competition by Players/Manufacturers
    2.1 China Oncolytic Virus Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Oncolytic Virus Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Oncolytic Virus Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.4 China Oncolytic Virus Market Competitive Situation and Trends
        2.4.1 China Oncolytic Virus Market Concentration Rate
        2.4.2 China Oncolytic Virus Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Oncolytic Virus Manufacturing Base Distribution, Sales Area, Product Types

3 China Oncolytic Virus Sales and Revenue by Region (2012-2017)
    3.1 China Oncolytic Virus Sales (K Units) and Market Share by Region (2012-2017)
    3.2 China Oncolytic Virus Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Oncolytic Virus Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Oncolytic Virus Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Oncolytic Virus Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Oncolytic Virus Price (USD/Unit) by Type (2012-2017)
    4.4 China Oncolytic Virus Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Oncolytic Virus Sales (K Units) and Market Share by Application (2012-2017)
    5.2 China Oncolytic Virus Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Oncolytic Virus Players/Suppliers Profiles and Sales Data
    6.1 Merck
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oncolytic Virus Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Otsuka Pharmaceutical Co
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Oncolytic Virus Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Pfizer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Oncolytic Virus Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Pfizer Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Roche
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Oncolytic Virus Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Roche Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Cold Genesys
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Oncolytic Virus Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Cold Genesys Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Genelux
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Oncolytic Virus Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Genelux Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Latima
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Oncolytic Virus Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Latima Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Neotropix
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Oncolytic Virus Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Neotropix Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Shanghai Sunway Biotech
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Oncolytic Virus Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 SillaJen
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Oncolytic Virus Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 SillaJen Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Takara Bio
    6.12 Theravir

7 Oncolytic Virus Manufacturing Cost Analysis
    7.1 Oncolytic Virus Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oncolytic Virus

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oncolytic Virus Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oncolytic Virus Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Oncolytic Virus Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Oncolytic Virus Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Oncolytic Virus Sales (K Units) Forecast by Type (2017-2022)
    11.3 China Oncolytic Virus Sales (K Units) Forecast by Application (2017-2022)
    11.4 China Oncolytic Virus Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List